Gene Therapy for Rare Inherited Retinal Diseases Shows Promise: BEST1 Patient Presentation.

The article discusses gene therapy for rare inherited retinal diseases, focusing on the company's progress in delivering on its promise. The presentation highlights data from clinical trials and future enrollment, as well as the company's pipeline of additional indications. The company's success in this area has the potential to significantly impact the treatment of rare diseases.